Resuscitation and oxygenation
›Oxygenation strategy
›Supplemental oxygen escalation ladder
›Nasal cannula
›Flow titration to SpO2 target
›Nonrebreather mask
›High flow oxygen
›High flow nasal cannula
›FiO2 titration to SpO2 target
›Flow titration for work of breathing
›Noninvasive ventilation
›CPAP for pulmonary edema physiology
›BiPAP for hypercapnia physiology
›Endotracheal intubation
›Refractory hypoxemia
›Inability to protect airway
›Severe work of breathing
Ventilation and airway procedures
›Airway management
›Bag mask ventilation optimization
›Two person technique
›PEEP valve use when available
›RSI medication options
›Etomidate IV 0.3 mg per kg
›Hemodynamic instability preference
›Adrenal suppression consideration
›Ketamine IV 1 to 2 mg per kg
›Bronchospasm benefit
›Hypotension monitoring
›Rocuronium IV 1.2 mg per kg
›Long paralysis duration planning
›Post intubation sedation requirement
›Succinylcholine IV 1 to 1.5 mg per kg
›Hyperkalemia risk screening
›Contraindications review
›Post intubation ventilation
›Lung protective ventilation
›Tidal volume 6 mL per kg predicted body weight
›Plateau pressure target 30 cm H2O or less
›PEEP strategy
›Moderate to high PEEP for alveolar recruitment
›Hemodynamic tolerance monitoring
›ARDS management pathway
›Prone positioning for severe hypoxemia
›Neuromuscular blockade short course if ventilator dyssynchrony
›Hemodynamic support
›Crystalloid bolus strategy
›Hypotension with clinical hypovolemia
›Pulmonary edema risk reassessment each bolus
›Vasopressors
›Norepinephrine infusion initiation for persistent hypotension
›Titration to MAP target
›Extravasation monitoring
›Post arrest care
›Targeted temperature management per institutional protocol
›Avoid fever
Bronchospasm and pulmonary care
›Pulmonary adjuncts
›Inhaled beta agonist
›Salbutamol inhaled 4 to 8 puffs via spacer
›Repeat dosing based on response
›Tachycardia monitoring
›Nebulized beta agonist
›Salbutamol 2.5 to 5 mg nebulized
›Repeat every 20 minutes for severe bronchospasm
›Continuous nebulization consideration in ICU
›Steroids
›Routine use not supported for drowning lung injury
›Asthma or COPD exacerbation indication only
Aspiration and antibiotics
›Infection management
›Prophylactic antibiotics avoidance
›No routine antibiotics without clinical infection
›Chemical pneumonitis supportive care focus
›Pneumonia treatment triggers
›Fever
›Leukocytosis with clinical deterioration
›New radiographic infiltrate with symptoms
›Empiric antibiotic selection framework
›Community aspiration pneumonia regimen per local antibiogram
›Water exposure organisms consideration
›Freshwater gram negative risk consideration
›MRSA coverage only with risk factors and severe pneumonia criteria
Hypothermia and rewarming
›Rewarming strategy
›Mild hypothermia
›Passive external rewarming
›Warmed blankets
›Moderate to severe hypothermia
›Active external rewarming
›Forced air warming
›Warmed IV fluids
›Active internal rewarming
›Warmed humidified oxygen
›Lavage options per institutional capability
›Hypothermic arrest pathway
›Prolonged resuscitation consideration
›ECMO consideration in selected hypothermic OHCA
›Neurologic management
›Benzodiazepines for active seizures
›Lorazepam IV 0.1 mg per kg
›Maximum single dose 4 mg
›Repeat once if persistent seizure
›Midazolam IM 0.2 mg per kg
›Maximum single dose 10 mg
›IV access delay use case
›Second line anticonvulsant
›Levetiracetam IV 60 mg per kg
›Maximum 4500 mg
›Renal dosing adjustment consideration
›Sedation for ventilated patients
›Propofol infusion contraindication screening
›Analgesia first strategy with fentanyl